Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Catalyst Bio
(NQ:
CBIO
)
0.3700
-0.0300 (-7.50%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 18, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
59,968
Open
0.3900
Bid (Size)
0.3700 (32)
Ask (Size)
0.4093 (14)
Prev. Close
0.4000
Today's Range
0.3700 - 0.4093
52wk Range
0.3501 - 5.200
Shares Outstanding
31,477,053
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Recap: Catalyst Biosciences Q1 Earnings
May 09, 2022
Catalyst Biosciences (NASDAQ:CBIO) reported its Q1 earnings results on Monday, May 9, 2022 at 08:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Looking Into Catalyst Biosciences's Return On Capital Employed
April 01, 2022
According to data from Benzinga Pro, during Q4, Catalyst Biosciences's (NASDAQ:CBIO) reported sales totaled $2.44 million. Despite a 19.45% increase in earnings, the company posted a loss of $20.33...
Via
Benzinga
Performance
YTD
-63.00%
-63.00%
1 Month
-28.91%
-28.91%
3 Month
-27.86%
-27.86%
6 Month
-75.97%
-75.97%
1 Year
-91.13%
-91.13%
More News
Read More
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 15, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 17, 2022
Via
Benzinga
U.S. Xpress Enterprises And 4 Other Penny Stocks Bought By Insiders
February 17, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 16, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 07, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
February 07, 2022
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
January 26, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
January 31, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 25, 2022
Via
Benzinga
25 Stocks Moving in Monday's Pre-Market Session
December 20, 2021
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
January 07, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 15, 2021
November 15, 2021
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 12, 2021
Via
Benzinga
70 Biggest Movers From Friday
November 15, 2021
Via
Benzinga
Looking Into Catalyst Biosciences's Return On Capital Employed
November 12, 2021
Via
Benzinga
48 Stocks Moving In Friday's Mid-Day Session
November 12, 2021
Via
Benzinga
What Is Happening With Catalyst Biosciences Shares Today?
November 12, 2021
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 12, 2021
Via
Benzinga
The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts
October 14, 2021
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
Via
Benzinga
Exposures
Product Safety
Catalyst Biosciences' Lead Candidate Secures Orphan Drug Tag For Blood Clotting Disorder
September 29, 2021
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 10, 2021
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
September 09, 2021
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.